Heranba Industries Limited, one of India’s leading Synthetic Pyrethroids and its intermediates manufacturer in India, has reported income of Rs. 355.7 crore in Q1 FY22 as compared to Rs. 269.28 crore in Q1 FY21, a growth of 32.09% Y-o-Y and growth of 30.20% Q-o-Q.

EBITDA (including other income) at Rs. 69 crore in Q1 FY22 as compared to Rs. 43.6 crore in Q1 FY21, a growth of 58.59% Y-o-Y and growth of 9.59% Q-o-Q. EBITDA (including other income) Margins were at 19.66% in Q1 FY22 as compared to 16.19% in Q1FY21, a growth of approximatel 348 bps Y-o-Y and de-growth of 388bps Q-o-Q.

Profit After Tax in Q1 FY22 was Rs. 47.39 crore as compared to Rs. 28.58 crore in Q1 FY21, a growth of 65.79% Y-o-Y and growth of 9.69% Q-o-Q.

Raghuram K. Shetty, Managing Director, Heranba Industries Limited said, “The company's first-quarter success reflects the strong and increasing demand for our innovative products, our ability to price for the value we bring, our operational agility, and our emphasis on execution in a dynamic operating environment. In this rather difficult period of COVID-19 second wave we have been able to increase our revenue by 32.09%. We are dedicated to accelerating revenue growth and productivity efforts in order to achieve significant margin expansion, and we continue to view FY22 as a crucial acceleration point in Heranba's trajectory.”